Botulinum toxin in aesthetic applications: 'How often misused words generate misleading thoughts'

Journal of Cosmetic and Laser Therapy

Volumn 11, Issue 3, 2009, Pages 178-179

  Pickett, Andy ^a   Rzany, Berthold ^b  

^a IPSEN   (France)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ACCURACY; ADVERSE DRUG REACTION; CLINICAL TRIAL; DRUG DIFFUSION; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; EYEBROW ASYMMETRY; EYELID HEAVINES; HEAVY EYEBROW; HUMAN; INABILITY TO SHOW FACIAL EXPRESSION; LETTER; METHODOLOGY; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; UNNATURAL EYEBROW; WRINKLE;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; HUMANS; NEUROMUSCULAR AGENTS; RESEARCH DESIGN; SKIN AGING;

EID: 68849112333     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14764170902842523     Document Type: Letter

References (16)

1. Carruthers A, Carruthers J. Long-term safety review of subjects treated with botulinum toxin type A (BoNT/A) for cosmetic use. Presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins; June 23-25 2005, Denver, CO: Poster P03.
2. Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D on behalf of the German-Austrian Retrospective Study Group. Repeated Botulinum Toxin A injections for the treatment of lines in the upper face: a retrospective study of 4103 treatments in 945 patients. Dermatol Surg. 2007;33(s1):S18-25.
3. Krack P, Deuschl G, Benecke R, Ceballos-Baumann AO, Marion M-H, Oertel WH, et al. Dose standardisation of botulinum toxin. Mov Disord. 1998;13:749-753
4. Pickett A, Dodd S, Rzany B. Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications. J Cosmet Laser Ther. 2008;10:181-183
5. Rzany B, Nast A. Head-to-head studies of botulinum toxin A in aesthetic medicine: which evidence is good enough? J Am Acad Dermatol. 2007;56:1066-1067
6. De Maio M, Rzany B. Botulinum toxin in aesthetic medicine. Heidelberg: Springer; 2007.
7. Pickett A, Caird D. Comparison of type A botulinum toxin products in clinical use. J Clin Pharm Therapeut. 2008;33:327-328 (Pubitemid 351629749)
8. De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008;10:87-92. (Pubitemid 351883324)
9. Williams H, Naldi L, Bigby M, Herxheimer A, Diepgen T, Rzany B. Evidence-based dermatology. 2nd edn. London: Blackwell BMJ Books; 2008.
10. Fick A. Ann Physik. 1855;23:59
11. as cited by Bloomfield VA. Survey of biomolecular hydrodynamics. In: Schuster TM, editor. Biophysics textbook on-line (BTOL) - Volume: Separations and hydrodynamics; 2000. p. 1-16.
12. Pickett A. Dysport®: Pharmacological properties and factors that influence toxin action. Presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins (Toxins 2008); 12-15 July 2008, Baveno, Italy.
13. Pickett A. Diffusion of botulinum toxin in vivo is not related to the size of the toxin complex. Presented at the 5th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins (Toxins 2008); 12-15 July 2008, Baveno, Italy. Poster P3.28.
14. Trinidade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007;33:S37-43. (Pubitemid 46051398)
15. Hexsel D, Dal'Forno T, Hexsel C, do Prado DZ, Lima MM. A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A. Dermatol Surg. 2007;34:1-8.
16. Karsai S, Raulin C. Do different formulations of botulinum toxin type A really have different migration characteristics? J Cosmet Dermatol. 2008;7:230.